Search for

List of Strains Covered

Suggested search words: constipation diarrhea cough cancer ibs crohn mood stress allergy flu IL-10 obesity

ProbioticSellerStudy (Click to View)
Aspergillus oryzae NK strong wakamoto w Study of the mechanisms of a Japanese traditional fermented medicine in the improvement of constipation.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Different effects of Bacillus coagulans vegetative cells and spore isolates on constipation-induced gut microbiota dysbiosis in mice.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Alleviation of low-fiber diet-induced constipation by probiotic <i>Bifidobacterium bifidum</i> G9-1 is based on correction of gut microbiota dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Correction: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Corrigendum: Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Effect of probiotics, <i>Bifidobacterium bifidum</i> G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study).
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium lactis BB-12 Nestlé [Effect of probiotics on the dynamics of gastrointestinal symptoms of food allergy to cow`s milk protein in infants].
Bifidobacterium lactis BB-12 Nestlé Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults.
Bifidobacterium lactis Bi-07 UltraFlora® Balance A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis bi-07) in improving symptoms of constipation.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Bifidobacterium lactis Bi-07 UltraFlora® Balance The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of <i>Bifidobacterium longum</i> and <i>Lactobacillus rhamnosus</i> on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood.
Bifidobacterium longum R0175 Calm Biotic® Efficacy of <i>Lactobacillus paracasei</i> HA-196 and <i>Bifidobacterium longum</i> R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study.
Bifidobacterium longum subsp. infantis NLS Life Start 2 Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease.
Bifidobacterium longum W108 Ecologic® Relief Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Lactobacillus acidophilus CL1285 Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Lactobacillus acidophilus NCFM UltraFlora® Balance A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation.
Lactobacillus acidophilus NCFM UltraFlora® Balance EFFECTS OF SYNBIOTIC SUPPLEMENTATION ON GUT FUNCTIONING AND SYSTEMIC INFLAMMATION OF COMMUNITY-DWELLING ELDERS - SECONDARY ANALYSES FROM A RANDOMIZED CLINICAL TRIAL.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Lactobacillus acidophilus NCFM UltraFlora® Balance The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Lactobacillus casei LBC80R Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Lactobacillus casei Shirota Yakult [Probiotics as therapeutic agents in irritable bowel syndrome].
Lactobacillus casei Shirota Yakult <i>Lactobacillus casei</i> Strain Shirota Alleviates Constipation in Adults by Increasing the Pipecolinic Acid Level in the Gut.
Lactobacillus casei Shirota Yakult Differential Effects of <i>Lactobacillus casei</i> Strain Shirota on Patients With Constipation Regarding Stool Consistency in China.
Lactobacillus casei Shirota Yakult Effect of fermented milk containing Lactobacillus casei strain Shirota on constipation-related symptoms and haemorrhoids in women during puerperium.
Lactobacillus casei Shirota Yakult Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study.
Lactobacillus casei Shirota Yakult Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus casei Shirota Yakult Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study.
Lactobacillus casei Shirota Yakult Effects of the continuous intake of a milk drink containing Lactobacillus casei strain Shirota on abdominal symptoms, fecal microbiota, and metabolites in gastrectomized subjects.
Lactobacillus casei Shirota Yakult Efficacy of probiotics on digestive disorders and acute respiratory infections: a controlled clinical trial in young Vietnamese children.
Lactobacillus casei Shirota Yakult Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population.
Lactobacillus casei Shirota Yakult Improving the bowel habits of elderly residents in a nursing home using probiotic fermented milk.
Lactobacillus casei Shirota Yakult Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.
Lactobacillus casei Shirota Yakult Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials.
Lactobacillus casei Shirota Yakult Systematic review of randomised controlled trials: probiotics for functional constipation.
Lactobacillus casei Shirota Yakult The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.
Lactobacillus casei Shirota Yakult Use of probiotics for the treatment of constipation in Parkinson`s disease patients.
Lactobacillus casei W79 Ecologic® Relief Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Lactobacillus paracasei Lpc-37 Custom Probiotics The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support [Irritable bowel syndrome--irritable bowel or irritable mind?].
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany].
Lactobacillus plantarum W62 Ecologic® AAD Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Lactobacillus reuteri DSM 17938 BioGaia® "The role of L. reuteri DSM17938 in nutritional recovery and treatment of constipation in children and adolescents with anorexia nervosa - a randomized, double blind, placebo controlled study".
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study.
Lactobacillus reuteri DSM 17938 BioGaia® Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
Lactobacillus reuteri DSM 17938 BioGaia® Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation.
Lactobacillus reuteri DSM 17938 BioGaia® Lack of Benefit of Lactobacillus reuteri DSM 17938 as an Addition to the Treatment of Functional Constipation.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics in Functional Gastrointestinal Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics on Pediatric Functional Gastrointestinal Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics, prebiotics, and dietary fiber in the management of functional gastrointestinal disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.
Lactobacillus reuteri DSM 17938 BioGaia® The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.
Lactobacillus reuteri DSM 17938 BioGaia® The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence.
Lactobacillus reuteri DSM 17938 BioGaia® The good bugs: the use of probiotics in pediatrics.
Lactobacillus reuteri DSM 17938 BioGaia® The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.
Lactobacillus rhamnosus CLR2 Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Lactobacillus rhamnosus GG Culturelle® [Administration of probiotic lactobacilli to children with gastrointestinal problems: there is still little evidence].
Lactobacillus rhamnosus GG Culturelle® Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children.
Lactobacillus rhamnosus GG Culturelle® Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects.
Lactobacillus rhamnosus GG Culturelle® Cytokine-specific autoantibodies shape the gut microbiome in autoimmune polyendocrine syndrome type 1.
Lactobacillus rhamnosus GG Culturelle® Decrease of Postchemotherapy Complications With the Use of Probiotics in Children With Acute Lymphoblastic Leukemia.
Lactobacillus rhamnosus GG Culturelle® Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
Lactobacillus rhamnosus GG Culturelle® Investigation of the Efficacy of Lactobacillus rhamnosus GG in Infants With Cow`s Milk Protein Allergy: a Randomised Double-Blind Placebo-Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics in Functional Gastrointestinal Disorders.
Lactobacillus rhamnosus GG Culturelle® Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study.
Lactobacillus rhamnosus GG Culturelle® Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain.
Lactobacillus rhamnosus GG Culturelle® Systematic review of randomised controlled trials: probiotics for functional constipation.
Lactobacillus rhamnosus GG Culturelle® The good bugs: the use of probiotics in pediatrics.
Lactobacillus rhamnosus GG Culturelle® The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.
Lactobacillus rhamnosus Lcr35 Provacare® Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
Lactobacillus rhamnosus Lcr35 Provacare® Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation.
Lactobacillus rhamnosus Lcr35 Provacare® Lactobacillus casei rhamnosus Lcr35 in the Management of Functional Constipation in Children: A Randomized Trial.
Lactobacillus rhamnosus Lcr35 Provacare® Systematic review of randomised controlled trials: probiotics for functional constipation.
Lactobacillus rhamnosus Lcr35 Provacare® Systematic review: probiotics for functional constipation in children.
Lactobacillus rhamnosus W71 Ecologic® AAD Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells.
Symbioflor 2 German Apotheke by Paul's Mart Probiotic treatment of irritable bowel syndrome in children.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. [The role of oral probiotic for bacterial vaginosis in pregnant women. A pilot study].

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)